Martin Roper sold $2.0M of COCO
Chief Executive Officer at Vita Coco Company, Inc.. 50,506 shares at an average of $40.12, traded Sep 15, 2025, filed Sep 23, 2025.
Score components
- +25RoleCEO
- +25Trade size$2.0M at market
- +5Share of holdings soldSold 14% of holdings
- +15Cluster9 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000908834-25-000295, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 15, 2025 | SOpen-market sale Common Stock10b5-1 | -5,000 | $40.09 | $200k | 347,062 | Sep 23, 2025 |
| Sep 16, 2025 | SOpen-market sale Common Stock10b5-1 | -2,765 | $40.01 | $111k | 344,297 | Sep 23, 2025 |
| Sep 17, 2025 | SOpen-market sale Common Stock10b5-1 | -5,000 | $40.22 | $201k | 339,297 | Sep 23, 2025 |
| Sep 15, 2025 | SOpen-market sale Common Stockindirect: by Chris Roper FT10b5-1 | -5,000 | $40.09 | $200k | 281,131 | Sep 23, 2025 |
| Sep 16, 2025 | SOpen-market sale Common Stockindirect: by Chris Roper FT10b5-1 | -2,325 | $40.00 | $93k | 278,806 | Sep 23, 2025 |
| Sep 17, 2025 | SOpen-market sale Common Stockindirect: by Chris Roper FT10b5-1 | -5,000 | $40.23 | $201k | 273,806 | Sep 23, 2025 |
| Sep 15, 2025 | SOpen-market sale Common Stockindirect: by Peter Roper FT10b5-1 | -5,000 | $40.09 | $200k | 281,131 | Sep 23, 2025 |
| Sep 16, 2025 | SOpen-market sale Common Stockindirect: by Peter Roper FT10b5-1 | -3,216 | $40.01 | $129k | 277,915 | Sep 23, 2025 |
| Sep 17, 2025 | SOpen-market sale Common Stockindirect: by Peter Roper FT10b5-1 | -5,000 | $40.22 | $201k | 272,915 | Sep 23, 2025 |
| Sep 15, 2025 | SOpen-market sale Common Stockindirect: by Thomas Roper FT10b5-1 | -5,000 | $40.08 | $200k | 281,131 | Sep 23, 2025 |
| Sep 16, 2025 | SOpen-market sale Common Stockindirect: by Thomas Roper FT10b5-1 | -2,200 | $40.01 | $88k | 278,931 | Sep 23, 2025 |
| Sep 17, 2025 | SOpen-market sale Common Stockindirect: by Thomas Roper FT10b5-1 | -5,000 | $40.23 | $201k | 273,931 | Sep 23, 2025 |
Related signals
Other insiders at Vita Coco Company, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 20Weak | Vita Coco Company, Inc. | Jonathan Burth Chief Operating Officer | $1.9M 37,666 shares | -40% | |
| 20Weak | Vita Coco Company, Inc. | Jonathan Burth Chief Operating Officer | $1.0M 22,334 shares | -28% | |
| 11Weak | Vita Coco Company, Inc. | Jonathan Burth Chief Operating Officer | $135k 3,173 shares | -4% | |
| 43Moderate | Vita Coco Company, Inc. | Martin Roper Chief Executive Officer | $890k 21,600 shares | -7% | |
| 50Moderate | Vita Coco Company, Inc. | Martin Roper Chief Executive Officer | $1.6M 40,000 shares | -12% | |
| 38Weak | Vita Coco Company, Inc. | Michael Kirban Executive Chairman | $831k 20,000 shares | -1% | |
| 42Moderate | Vita Coco Company, Inc. | Martin Roper Chief Executive Officer | $800k 20,000 shares | -6% | |
| 26Weak | Vita Coco Company, Inc. | Jonathan Burth Chief Operating Officer | $716k 16,827 shares | -18% | |
| 40Moderate | Vita Coco Company, Inc. | Michael Kirban Executive Chairman | $1.3M 30,000 shares | -2% | |
| 35Weak | Vita Coco Company, Inc. | Ira Liran director | $2.1M 50,000 shares | -7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.